In Billing
Feb 5th, 2018
The Clinical Laboratory Improvement Amendments of 1988 (CLIA) requires that only certified labs may bill for laboratory services, unless the test in question has been granted a waiver. The Centers for Medicare & Medicaid Services (CMS) has announced several new laboratory services, recently approved by the Food and Drug Administration (FDA), which qualify for a ...
In CMS
Sep 20th, 2016
by John Verhovshek, CPC, and Renee Dustman Reflecting United States Preventive Services Task Force (USPSTF) 2008 recommendations (2015 recommendations are in progress), Medicare Part B covers 100 percent of the Medicare-approved amount for fecal occult blood tests, flexible sigmoidoscopies, colonoscopies, and multi-target stool DNA tests, and 80 percent for barium enemas for colorectal cancer scr...
In Billing
May 22nd, 2013
Fecal occult blood testing (FOBT) detects the presence of trace amounts of blood in stool. Most payers will cover this service, but keep in mind there is a distinction between screening and diagnostic FOBT. Only two tests qualify as screenings: The first of these is the guaiac test (82270 Blood, occult, by peroxidase activity (eg, ...
In Billing
Jul 1st, 2011
The Centers for Medicare & Medicaid Services (CMS) released, June 17, the latest laboratory tests approved by the Food and Drug Administration (FDA) as waived tests under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). According to CMS Transmittal 2244, there will be five new tests that are covered under Medicare Parts A and B effective Oct. ...
In Billing
Apr 30th, 2010
Billing instructions for colorectal screening services will soon change. The new billing instructions apply to screening services provided to hospital inpatients submitted under Medicare Part B or when Part A benefits have been exhausted. New Billing Instructions for Colorectal Screening Services was last modified: July 5th, 2011 by admin aapc...